Sunshine Biopharma (SBFM) Non-Current Debt (2014 - 2021)
Sunshine Biopharma's (SBFM) quarterly Non-Current Debt came in at $1.9 million in Q4 2021, up 100.21% YoY from $949006.0 in Q4 2020, and down 40.7% on a QoQ basis from $3.2 million in Q3 2021.
Sunshine Biopharma (SBFM) Non-Current Debt (2014 - 2021) Analysis & Trends
Sunshine Biopharma (SBFM) has 8 years of Non-Current Debt data on file, last reported at $1.9 million in Q4 2021.
- Quarterly Non-Current Debt rose 100.21% year-over-year to $1.9 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $1.9 million (up 100.21% YoY) and the FY2021 annual result came in at $1.9 million, up 100.21% from the prior year.
- Non-Current Debt fell to $1.9 million in Q4 2021, from $3.2 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $3.2 million in Q3 2021 to a low of $63234.0 in Q2 2020.
- A 5-year average of $1.0 million and a median of $477064.5 in 2017 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2018 — Non-Current Debt plunged 51.41% — and 2021, when it soared 3148.59%.
- Tracing SBFM's Non-Current Debt over 5 years: stood at $596577.0 in 2017, then slumped by 51.41% to $289847.0 in 2018, then decreased by 0.01% to $289825.0 in 2019, then soared by 227.44% to $949006.0 in 2020, then surged by 100.21% to $1.9 million in 2021.
- The last three Non-Current Debt figures came in at $1.9 million (Q4 2021), $3.2 million (Q3 2021), and $2.1 million (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 130.00 Mn |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 1.90 Mn |
| Sep 30, 2021 | 3.20 Mn |
| Jun 30, 2021 | 2.05 Mn |
| Mar 31, 2021 | 2.08 Mn |
| Dec 31, 2020 | 949,006.00 |
| Sep 30, 2020 | 357,552.00 |
| Jun 30, 2020 | 63,234.00 |
| Mar 31, 2019 | 289,825.00 |
| Dec 31, 2018 | 289,847.00 |
| Sep 30, 2018 | 312,566.00 |
| Mar 31, 2018 | 322,021.00 |
| Dec 31, 2017 | 596,577.00 |
| Dec 31, 2016 | 69,939.00 |
| Dec 31, 2015 | 102,142.00 |
| Dec 31, 2014 | 480,124.00 |